Do analysts recommend VRX or BHC?

Given Valeant Pharmaceuticals International's higher possible upside, research analysts clearly believe Valeant Pharmaceuticals International is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Valeant Pharmaceuticals International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Bausch Health Companies 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings & valuation, VRX or BHC?

Valeant Pharmaceuticals International has higher earnings, but lower revenue than Bausch Health Companies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Valeant Pharmaceuticals International N/A N/A N/A N/A N/A Bausch Health Companies C$10.85B 0.29 -C$125.65M -C$2.94 N/A

Do analysts rate BHC or APHA?

Given Aphria's higher possible upside, analysts plainly believe Aphria is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Aphria 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings and valuation, BHC or APHA?

Bausch Health Companies has higher revenue and earnings than Aphria. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bausch Health Companies C$10.85B 0.29 -C$125.65M -C$2.94 N/A Aphria C$611.06M 0.00 -C$637.39M -C$2.01 N/A

Do analysts prefer MJN or BHC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Bausch Health Companies 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings and valuation, MJN or BHC?

Cronos Group has higher earnings, but lower revenue than Bausch Health Companies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cronos Group N/A N/A N/A N/A N/A Bausch Health Companies C$10.85B 0.29 -C$125.65M -C$2.94 N/A

Do analysts prefer BHC or CRON?

Cronos Group has a consensus target price of C$4.92, indicating a potential upside of 8.30%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts plainly believe Cronos Group is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Cronos Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00

Do analysts rate BHC or CARA?

Given Cara Operations' higher probable upside, analysts plainly believe Cara Operations is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Cara Operations 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better earnings & valuation, BHC or CARA?

Cara Operations has lower revenue, but higher earnings than Bausch Health Companies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bausch Health Companies C$10.85B 0.29 -C$125.65M -C$2.94 N/A Cara Operations N/A N/A N/A N/A N/A

Bausch Health Companies (BHC) Competitors

C$8.45 +0.09 (+1.08%)

As of 12:52 PM Eastern

Compare

BHC vs. VRX, APHA, MJN, CRON, and CARA

Should you buy Bausch Health Companies stock or one of its competitors? Bausch Health Companies's main competitors and comparable companies include Valeant Pharmaceuticals International (VRX), Aphria (APHA), Cronos Group (MJN), Cronos Group (CRON), and Cara Operations (CARA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Bausch Health Companies compare to Valeant Pharmaceuticals International?

Valeant Pharmaceuticals International (TSE:VRX) and Bausch Health Companies (TSE:BHC) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability, media sentiment and valuation.

In the previous week, Bausch Health Companies had 2 more articles in the media than Valeant Pharmaceuticals International. MarketBeat recorded 2 mentions for Bausch Health Companies and 0 mentions for Valeant Pharmaceuticals International. Bausch Health Companies' average media sentiment score of 1.22 beat Valeant Pharmaceuticals International's score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the news media.

Company	Overall Sentiment
Valeant Pharmaceuticals International	Neutral
Bausch Health Companies	Positive

Valeant Pharmaceuticals International has a net margin of 0.00% compared to Bausch Health Companies' net margin of -12.02%. Bausch Health Companies' return on equity of 87.57% beat Valeant Pharmaceuticals International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Valeant Pharmaceuticals International	N/A	N/A	N/A
Bausch Health Companies	-12.02%	87.57%	4.16%

Given Valeant Pharmaceuticals International's higher possible upside, research analysts clearly believe Valeant Pharmaceuticals International is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Valeant Pharmaceuticals International	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bausch Health Companies	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Valeant Pharmaceuticals International has higher earnings, but lower revenue than Bausch Health Companies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Valeant Pharmaceuticals International	N/A	N/A	N/A	N/A	N/A
Bausch Health Companies	C$10.85B	0.29	-C$125.65M	-C$2.94	N/A

9.5% of Bausch Health Companies shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Bausch Health Companies beats Valeant Pharmaceuticals International on 8 of the 10 factors compared between the two stocks.

How does Bausch Health Companies compare to Aphria?

Bausch Health Companies (TSE:BHC) and Aphria (TSE:APHA) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, media sentiment, risk, dividends and valuation.

In the previous week, Bausch Health Companies had 2 more articles in the media than Aphria. MarketBeat recorded 2 mentions for Bausch Health Companies and 0 mentions for Aphria. Bausch Health Companies' average media sentiment score of 1.22 beat Aphria's score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the media.

Company	Overall Sentiment
Bausch Health Companies	Positive
Aphria	Neutral

Aphria has a net margin of 0.00% compared to Bausch Health Companies' net margin of -12.02%. Bausch Health Companies' return on equity of 87.57% beat Aphria's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-12.02%	87.57%	4.16%
Aphria	N/A	N/A	N/A

Given Aphria's higher possible upside, analysts plainly believe Aphria is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aphria	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

9.5% of Bausch Health Companies shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Bausch Health Companies has higher revenue and earnings than Aphria. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.85B	0.29	-C$125.65M	-C$2.94	N/A
Aphria	C$611.06M	0.00	-C$637.39M	-C$2.01	N/A

Summary

Bausch Health Companies beats Aphria on 10 of the 13 factors compared between the two stocks.

How does Bausch Health Companies compare to Cronos Group?

Cronos Group (CVE:MJN) and Bausch Health Companies (TSE:BHC) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends.

In the previous week, Bausch Health Companies had 2 more articles in the media than Cronos Group. MarketBeat recorded 2 mentions for Bausch Health Companies and 0 mentions for Cronos Group. Bausch Health Companies' average media sentiment score of 1.22 beat Cronos Group's score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the news media.

Company	Overall Sentiment
Cronos Group	Neutral
Bausch Health Companies	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bausch Health Companies	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cronos Group has a net margin of 0.00% compared to Bausch Health Companies' net margin of -12.02%. Bausch Health Companies' return on equity of 87.57% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	N/A	N/A	N/A
Bausch Health Companies	-12.02%	87.57%	4.16%

Cronos Group has higher earnings, but lower revenue than Bausch Health Companies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	N/A	N/A	N/A	N/A	N/A
Bausch Health Companies	C$10.85B	0.29	-C$125.65M	-C$2.94	N/A

Summary

Bausch Health Companies beats Cronos Group on 8 of the 9 factors compared between the two stocks.

How does Bausch Health Companies compare to Cronos Group?

Bausch Health Companies (TSE:BHC) and Cronos Group (TSE:CRON) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk.

Cronos Group has a consensus target price of C$4.92, indicating a potential upside of 8.30%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts plainly believe Cronos Group is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Bausch Health Companies has a beta of 0.822142, suggesting that its share price is 18% less volatile than the broader market. Comparatively, Cronos Group has a beta of 1.288385, suggesting that its share price is 29% more volatile than the broader market.

9.5% of Bausch Health Companies shares are held by institutional investors. Comparatively, 4.4% of Cronos Group shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by insiders. Comparatively, 46.4% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Company	Overall Sentiment
Bausch Health Companies	Positive
Cronos Group	Neutral

Cronos Group has a net margin of 38.95% compared to Bausch Health Companies' net margin of -12.02%. Bausch Health Companies' return on equity of 87.57% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-12.02%	87.57%	4.16%
Cronos Group	38.95%	6.46%	-3.73%

Cronos Group has lower revenue, but higher earnings than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.85B	0.29	-C$125.65M	-C$2.94	N/A
Cronos Group	C$179.09M	9.34	-C$32.78M	C$0.19	23.89

Summary

Cronos Group beats Bausch Health Companies on 10 of the 16 factors compared between the two stocks.

How does Bausch Health Companies compare to Cara Operations?

Bausch Health Companies (TSE:BHC) and Cara Operations (TSE:CARA) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings.

In the previous week, Bausch Health Companies had 2 more articles in the media than Cara Operations. MarketBeat recorded 2 mentions for Bausch Health Companies and 0 mentions for Cara Operations. Bausch Health Companies' average media sentiment score of 1.22 beat Cara Operations' score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the media.

Company	Overall Sentiment
Bausch Health Companies	Positive
Cara Operations	Neutral

9.5% of Bausch Health Companies shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Given Cara Operations' higher probable upside, analysts plainly believe Cara Operations is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cara Operations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Cara Operations has lower revenue, but higher earnings than Bausch Health Companies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.85B	0.29	-C$125.65M	-C$2.94	N/A
Cara Operations	N/A	N/A	N/A	N/A	N/A

Cara Operations has a net margin of 0.00% compared to Bausch Health Companies' net margin of -12.02%. Bausch Health Companies' return on equity of 87.57% beat Cara Operations' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-12.02%	87.57%	4.16%
Cara Operations	N/A	N/A	N/A

Summary

Bausch Health Companies beats Cara Operations on 8 of the 10 factors compared between the two stocks.

Get Bausch Health Companies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BHC vs. The Competition

Export

Metric	Bausch Health Companies	Pharmaceuticals Industry	Healthcare Sector	TSE Exchange
Market Cap	C$3.16B	C$12.43B	C$7.28B	C$12.63B
Dividend Yield	0.76%	2.63%	2.51%	6.34%
P/E Ratio	-2.88	807.81	275.44	37.52
Price / Sales	0.29	748.21	559.80	8.41
Price / Cash	7.76	86.65	77.16	82.29
Price / Book	-3.96	9.19	10.66	4.36
Net Income	-C$125.65M	C$2.84B	C$3.50B	C$299.09M
7 Day Performance	-3.75%	-3.85%	-3.65%	-0.27%
1 Month Performance	2.55%	-7.95%	-8.06%	-2.32%
1 Year Performance	-1.51%	-5.71%	2.58%	14.22%

Bausch Health Companies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BHC Bausch Health Companies	0.6811 of 5 stars	C$8.45 +1.1%	N/A	-1.8%	C$3.16B	C$10.85B	N/A	20,300	Positive News
VRX Valeant Pharmaceuticals International	N/A	N/A	N/A	N/A	C$10.76B	N/A	N/A	N/A
APHA Aphria	N/A	N/A	N/A	N/A	C$5.24B	C$611.06M	N/A	1,200
MJN Cronos Group	N/A	C$12.15 -1.9%	N/A	+0.0%	C$1.73B	N/A	N/A	7,600
CRON Cronos Group	1.7158 of 5 stars	C$4.62 -1.1%	C$4.92 +6.4%	+29.0%	C$1.70B	C$179.09M	24.32	610

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:BHC) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bausch Health Companies (BHC) Competitors

BHC vs. VRX, APHA, MJN, CRON, and CARA

How does Bausch Health Companies compare to Valeant Pharmaceuticals International?

Summary

How does Bausch Health Companies compare to Aphria?

Summary

How does Bausch Health Companies compare to Cronos Group?

Summary

How does Bausch Health Companies compare to Cronos Group?

Summary

How does Bausch Health Companies compare to Cara Operations?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BHC vs. The Competition

Bausch Health Companies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bausch Health Companies (BHC) Competitors

BHC vs. VRX, APHA, MJN, CRON, and CARA

How does Bausch Health Companies compare to Valeant Pharmaceuticals International?

Does the media refer more to VRX or BHC?

Is VRX or BHC more profitable?

Do analysts recommend VRX or BHC?

Which has better earnings & valuation, VRX or BHC?

Do insiders and institutionals believe in VRX or BHC?

Summary

How does Bausch Health Companies compare to Aphria?

Does the media favor BHC or APHA?

Is BHC or APHA more profitable?

Do analysts rate BHC or APHA?

Do institutionals & insiders have more ownership in BHC or APHA?

Which has better earnings and valuation, BHC or APHA?

Summary

How does Bausch Health Companies compare to Cronos Group?

Do insiders & institutionals believe in MJN or BHC?

Does the media refer more to MJN or BHC?

Do analysts prefer MJN or BHC?

Is MJN or BHC more profitable?

Which has higher earnings and valuation, MJN or BHC?

Summary

How does Bausch Health Companies compare to Cronos Group?

Do analysts prefer BHC or CRON?

Which has more risk & volatility, BHC or CRON?

Do insiders and institutionals hold more shares of BHC or CRON?

Does the media refer more to BHC or CRON?

Is BHC or CRON more profitable?

Which has higher valuation and earnings, BHC or CRON?

Summary

How does Bausch Health Companies compare to Cara Operations?

Does the media refer more to BHC or CARA?

Do insiders & institutionals have more ownership in BHC or CARA?

Do analysts rate BHC or CARA?

Which has better earnings & valuation, BHC or CARA?

Is BHC or CARA more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BHC vs. The Competition

Bausch Health Companies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools